Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women.

Archives of internal medicine
Jan 2008
Citations:211
Influential Citations:11
Interventional (Human) Studies
89
S2 IconPDF Icon

Enhanced Details

Methods
1-year, population-based, double-blind, randomized controlled trial; 302 ambulant community-dwelling women aged 70-90 years in Perth, Australia; history of a fall in the previous 12 months; serum 25-hydroxyvitamin D < 24 ng/mL.
Intervention
Calcium citrate 1000 mg/day (four 250 mg tablets: two in the morning with breakfast and two in the evening with dinner); ergocalciferol 1000 IU/day; duration 12 months; taken with meals (ergocalciferol with the evening meal).
Results
Adding ergocalciferol to calcium citrate reduced the risk of having at least one fall over 1 year by about 19% (adjusted RR 0.61; 95% CI 0.37–0.99; 53.0% vs 62.9% fell). The reduction was significant for first fall in winter/spring (first fall 25.2% vs 35.8%; OR 0.55; 95% CI 0.32–0.96; RR 0.77). It also reduced the proportion with exactly one fall (21.2% vs 33.8%; OR 0.50; 95% CI 0.28–0.88) but not multiple falls. Conclusion: in sunny climates, ergocalciferol 1000 IU/d added to calcium reduces fall risk in vitamin D–insufficient elderly women, especially in winter; maintaining average 25OHD around 21.7–24 ng/mL may be protective; target ≥24 ng/mL for at-risk individuals.
Limitations
Height imbalance at baseline between groups; seasonal variation in falls and vitamin D status; use of ergocalciferol (D2) rather than cholecalciferol (D3) and potential potency differences; limited generalizability to men, younger individuals, or less sunny climates; falls measured by self-report with follow-up every 6 weeks.

Abstract

BACKGROUND Ergocalciferol (vitamin D(2)) supplementation plays a role in fall prevention, but the effect in patients living in the community in sunny climates remains uncertain. We evaluated the effect of ergocalciferol and calcium citrate supplement...